Matches in Nanopublications for { ?s ?p "[Confirmation of these findings is needed before the Kozak sequence variant can be accepted as a potential marker for personalized treatment of affective disorders with drugs targeting the metabotropic glutamate receptor 3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[Confirmation of these findings is needed before the Kozak sequence variant can be accepted as a potential marker for personalized treatment of affective disorders with drugs targeting the metabotropic glutamate receptor 3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Confirmation of these findings is needed before the Kozak sequence variant can be accepted as a potential marker for personalized treatment of affective disorders with drugs targeting the metabotropic glutamate receptor 3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP602135.RAn8QMhq7GTQZp6OAlpb-f0VUO9F9pe8VbIGdXxCEw4gU130_assertion description "[Confirmation of these findings is needed before the Kozak sequence variant can be accepted as a potential marker for personalized treatment of affective disorders with drugs targeting the metabotropic glutamate receptor 3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602135.RAn8QMhq7GTQZp6OAlpb-f0VUO9F9pe8VbIGdXxCEw4gU130_provenance.
- NP435644.RAajeyf1rwRdMPGLq89j2jd8d3oOQbJM4No8wFDirI8JQ130_assertion description "[Confirmation of these findings is needed before the Kozak sequence variant can be accepted as a potential marker for personalized treatment of affective disorders with drugs targeting the metabotropic glutamate receptor 3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435644.RAajeyf1rwRdMPGLq89j2jd8d3oOQbJM4No8wFDirI8JQ130_provenance.
- NP1068246.RAtVOE5bh8l-IIcm6q1AZCCg95Ips7j-3_z0DM48gbE_w130_assertion description "[Confirmation of these findings is needed before the Kozak sequence variant can be accepted as a potential marker for personalized treatment of affective disorders with drugs targeting the metabotropic glutamate receptor 3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1068246.RAtVOE5bh8l-IIcm6q1AZCCg95Ips7j-3_z0DM48gbE_w130_provenance.